Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QUICK: Risedronate for Vascular Calcification in ESRD
NCT00687661Phase 3Completed
- Sponsor
- Queen's University
- Start
- Oct 2008
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Vascular calcification comparing Risedronate with Placebo (2 arms). Primary endpoint: Coronary Artery Calcification at 24 months. Started Oct 2008; status: completed.
02
Drugs
risedronate
03
Conditions
Vascular calcification
Beyond the preview
Go deeper on NCT00687661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00687661.